Article
11β-HSD1 inhibitor efficacy in type 2 diabetes is cortisol-dependent
2024-05-10
Abstract excerpt
<h4>ABSTRACT</h4> Cortisol excess drives multiple adverse effects including hypertension, dyslipidemia, and delayed wound healing. Activation of cortisol by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) has shown promise as a therapeutic target for these comorbidities but clinical progress has been hampered by variable 11β-HSD1 inhibitor efficacy. Here, transcriptomic profiling of 11β-HSD1 target g...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 80088291-1280-5433-a151-333496c55255
- DOI
- 10.1101/2024.05.10.24307180
